Vivos Therapeutics, Inc.

8-K Entered a material agreement; Director or officer change Aug 3, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws Jul 7, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 25, 2026 8-K Other events Jun 16, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 16, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Delisting notice or listing-rule failure; Unregistered sale of equity; Regulation FD disclosure Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 20, 2026 8-K Delisting notice or listing-rule failure Apr 22, 2026 8-K Results of operations (earnings release) Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Entered a material agreement; Unregistered sale of equity Apr 3, 2026 8-K Director or officer change Feb 6, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 20, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jan 16, 2026 8-K Other events Dec 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 5, 2025 8-K Results of operations (earnings release) Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Shareholder vote results Nov 4, 2025 8-K Other events Oct 24, 2025 8-K Other events Sep 18, 2025 8-K Other events Sep 12, 2025 8-K/A Completed an acquisition or disposition; Other events Aug 25, 2025 8-K Results of operations (earnings release) Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jun 13, 2025 8-K Changed accountants Jun 6, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 23, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement Apr 17, 2025 8-K Results of operations (earnings release) Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Entered a material agreement; Director or officer change Feb 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 23, 2024 8-K Shareholder vote results Nov 27, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 20, 2024 8-K Other events Sep 18, 2024